{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:54:22Z","timestamp":1791262462124,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The transportability of models for postoperative high-volume cervical nodal disease in papillary thyroid carcinoma (PTC) and the incremental predictive value of molecular variables remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed models in the public Deyang cohort (521 patients; 90 events) and performed geographic external validation in the independent Liaocheng cohort (193 patients; 73 events). The outcome was &amp;gt;5 pathologically confirmed metastatic cervical lymph nodes. Five algorithms were compared using repeated stratified nested cross-validation with a prespecified 10-variable postoperative feature set. Ridge logistic regression (C\u00a0=\u00a00.1) was selected and applied without refitting. Paired comparisons of 8-variable clinicopathological and 10-variable clinicopathological\u2013molecular models assessed the incremental value of high-risk co-mutation status and mutation count in both cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Internal validation yielded an area under the receiver operating characteristic curve (AUROC) of 0.795 (95% CI, 0.745\u20130.842), average precision (AP) of 0.497 (0.406\u20130.598), and Brier score of 0.115 (0.098\u20130.134). External AUROC was 0.752 (0.678\u20130.821), AP 0.601 (0.498\u20130.728), and Brier score 0.217 (0.180\u20130.254). Observed and mean predicted risks were 37.8% and 23.9%, respectively; the observed-to-expected ratio was 1.582 (1.319\u20131.860) and the weak-calibration slope was 0.831 (0.542\u20131.191). At the prespecified threshold of 0.158, sensitivity was 0.795 and specificity 0.600. Net benefit was 0.254 for the model and 0.261 for classifying all patients as high risk (difference, \u22120.008; 95% CI, \u22120.051 to 0.033). External paired differences after adding molecular variables were +0.002 for AUROC (\u22120.005 to 0.010), \u22120.002 for AP (\u22120.016 to 0.010), \u22120.001 for Brier score (\u22120.002 to 0.000), and +0.009 for net benefit (\u22120.003 to 0.026).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The model retained moderate discrimination across centers but underestimated absolute risk and did not demonstrate a net benefit advantage over classifying all patients as high risk at the prespecified threshold. High-risk co-mutation status and mutation count showed no clear incremental predictive value. Further validation with standardized lymph-node assessment and patient outcomes is required before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1963925","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:27Z","timestamp":1791260787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High-volume cervical lymph node metastasis in papillary thyroid carcinoma: development and external validation of an interpretable prediction model"],"prefix":"10.3389","volume":"16","author":[{"given":"Dehao","family":"Wang","sequence":"first","affiliation":[{"name":"School of Medicine, Shandong First Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchao","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Shandong First Medical University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Hernia Surgery, Liaocheng People\u2019s Hospital Affiliated to Shandong First Medical University","place":["Liaocheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqing","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Thyroid, Breast and Hernia Surgery, Liaocheng People\u2019s Hospital Affiliated to Shandong First Medical University","place":["Liaocheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0541","article-title":"Impact of extranodal extension on risk stratification in papillary thyroid carcinoma","volume":"29","author":"Kim","year":"2019","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30665","article-title":"Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: interim results from the multicenter prospective PRO-IMPACT study","volume":"123","author":"Gore","year":"2017","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904819","article-title":"Clinical and genomic risk to guide the use of adjuvant therapy for breast cancer","volume":"380","author":"Sparano","year":"2019","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Agrawal","year":"2014","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","article-title":"Association between BRAF V600E mutation and recurrence of papillary thyroid cancer","volume":"33","author":"Xing","year":"2015","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5770","article-title":"Integrated gene profiling of fine-needle aspiration sample improves lymph node metastasis risk stratification for thyroid cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1728045","article-title":"Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma","volume":"16","author":"Yu","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EC-22-0457","article-title":"Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review","volume":"12","author":"Luisa Garo","year":"2023","journal-title":"Endocr Connect"},{"key":"B16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12957-024-03566-4","article-title":"Meta-analysis of prediction models for predicting lymph node metastasis in thyroid cancer","volume":"22","author":"Liu","year":"2024","journal-title":"World J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15828","DOI":"10.1038\/s41598-024-66304-6","article-title":"Development and validation of a clinical predictive model for high-volume lymph node metastasis of papillary thyroid carcinoma","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1613672","article-title":"Multimodal ultrasonographic and clinicopathological model for predicting high-volume lymph node metastasis in cN0 papillary thyroid carcinoma","volume":"16","author":"Qian","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.21037\/gs-2026-0217","article-title":"Clinical transportability, calibration drift, and local updating of a B-mode ultrasound radiomics-clinical prediction model for occult high-volume central lymph node metastasis in cN0 papillary thyroid carcinoma: development, temporal validation, and external validation","volume":"15","author":"Zhang","year":"2026","journal-title":"Gland Surg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4274\/dir.2026.264048","article-title":"Preoperative prediction of occult high-volume central lymph node metastasis in clinically node-negative papillary thyroid carcinoma using a multimodal practical model: development, temporal validation, and external validation","author":"Zhang","year":"2026","journal-title":"Diagn Interv Radiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5061\/dryad.bvq83bkpx","article-title":"Data from: Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma","author":"Yu","year":"2026","journal-title":"Dryad"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B24","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017"},{"key":"B25","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1145\/2939672.2939785","article-title":"XGBoost: a scalable tree boosting system","author":"Chen","year":"2016"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.753678","article-title":"A preoperative nomogram for the prediction of high-volume central lymph node metastasis in papillary thyroid carcinoma","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.21037\/gs-24-308","article-title":"Radiomics and deep learning for large volume lymph node metastasis in papillary thyroid carcinoma","volume":"13","author":"Ni","year":"2024","journal-title":"Gland Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"35313","DOI":"10.1038\/s41598-025-19345-4","article-title":"Preoperative prediction of lymph node metastasis risk in papillary thyroid carcinoma based on multiple model comparisons","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1551108","article-title":"Construction and validation of a predictive model for lymph node metastasis in patients with papillary thyroid carcinoma","volume":"16","author":"Hao","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0350","article-title":"Effects of coexistent BRAF V600E and TERT promoter mutations on poor clinical outcomes in papillary thyroid cancer: a meta-analysis","volume":"27","author":"Moon","year":"2017","journal-title":"Thyroid"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1857","article-title":"A molecular approach combined with American Thyroid Association classification better stratifies recurrence risk of classic histology papillary thyroid cancer","volume":"8","author":"Lin","year":"2019","journal-title":"Cancer Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics","volume":"17","author":"Van Calster","year":"2019","journal-title":"BMC Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074820","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-40","article-title":"External validation of multivariable prediction models: a systematic review of methodological conduct and reporting","volume":"14","author":"Collins","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6","article-title":"Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests","volume":"352","author":"Vickers","year":"2016","journal-title":"BMJ"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9025","article-title":"Minimum sample size for external validation of a clinical prediction model with a binary outcome","volume":"40","author":"Riley","year":"2021","journal-title":"Stat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1963925\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:26:30Z","timestamp":1791260790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1963925\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1963925"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1963925","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"article-number":"1963925"}}